InflammationNCT02416843
Metabolic and Immune System Responses to a Mixed Meal
A study testing Consumption of a mixed meal in people with Inflammation, run by University of Bath at 1 site in United Kingdom.
Trial summary
Overweight and obesity are major problems and their complications such as cardiovascular disease and type 2 diabetes mellitus pose great burdens on healthcare systems. There is accumulating evidence to support obesity being a chronic inflammatory disorder mediated in part by the expansion of adipose (fat) tissue. Read more about this study
- Who is it for?
- Ages 35 to 55 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Inflammation
- What is being tested?
- Consumption of a mixed meal
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Sep 2011to Nov 2014
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 55 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Subjects should be:
- Nonsmokers
- Weight stable for more than 3 months
Who cannot join
- Subjects should not :
- have a personal history of/existing cardiovascular disease, metabolic disease or dyslipidaemia
- be taking medications that may influence lipid or carbohydrate metabolism
- have food intolerances/allergies to any component of the meal (i.e. dairy or wheat)
- Perform no more than 6 hours of strenuous physical activity or 10 hours of moderate intensity physical activity per week (as these individuals will not fit the meal standardisation procedure)
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
University of Bath - Department for Health
Bath, Bath and North East Somerset, BA2 7AY
About this study
Official title: Metabolic and Immune System Responses to a Mixed Meal in Human Adipose Tissue and the Circulation
Overweight and obesity are major problems and their complications such as cardiovascular disease and type 2 diabetes mellitus pose great burdens on healthcare systems. There is accumulating evidence to support obesity being a chronic inflammatory disorder mediated in part by the expansion of adipose (fat) tissue.
Knowledge of the role of adipose tissue itself has changed dramatically and it has emerged that in addition to storing energy as fats; adipose tissue secretes and responds to various chemical messengers in the body that are related to metabolism and inflammation. After a meal has been consumed, changes in metabolic (and some inflammatory) markers are seen in the blood, which may be influenced by metabolic and inflammatory changes occuring in the adipose tissue itself.
Read more
The investigators therefore plan to investigate these changes in adipose tissue before and after a meal and compare them to changes occurring in the blood. They also plan to investigate whether these responses are different in people who are overweight compared to 'normal' weight.
Participants will include males aged between 35-55 years who fit the criteria for inclusion. After taking some preliminary measurements and monitoring of normal daily activities, participants will attend one day of Laboratory testing in the Physiology Laboratories at the University of Bath.
By investigating differences in metabolism and inflammation in adipose tissue and the circulation it is hoped that more will be learnt about the development of diseases associated with being overweight and ultimately help to develop more effective methods for prevention and treatment.
Read the detailed description
The aim of this research is to investigate differences in metabolism and inflammation in adipose tissue and the circulation in response to a meal with increasing adiposity. It is hypothesised that participants with increased fat mass, will have a more pronounced inflammatory response to a meal compared to participants with a 'healthy' weight. The inflammatory response will be assessed by measuring changes in gene expression and protein secretion in the adipose tissue and by measuring markers of metabolism, insulin resistance, cardiovascular disease and inflammation in the blood.
Following advertisement of the study, interested potential participants will be asked to contact the Chief Investigator for further information via email/telephone correspondence. There will be an initial assessment of eligibility based on inclusion/exclusion criteria and, if these requirements are met, the potential participant will be invited to a meeting to further discuss the trial. After they have read the participant information sheet and seen the flowchart outlining the timeline for the study, if they would like to take part, they will be asked to sign a consent form. Dates will then be scheduled for some preliminary anthropometric measurements to be taken, 9 days of physical activity monitoring and the trial date (1 full day in the laboratory only).
Preliminary measurements:
Preliminary testing will include anthropometric measurements of height, weight, waist and hip circumferences, sagittal waist height and blood pressure. These measurements will take place at the University of Bath Physiology Laboratories.
Physical activity monitoring:
For 9 days, participants will be fitted with a physical activity monitor (Actiheart™) and asked to record a corresponding diary of their physical activity during this period to aid its interpretation and allow a more accurate calculation of average daily activity energy expenditure. Participants should not make any conscious changes to their normal lifestyle habits/routines during this period. The first 2 days of activity monitoring will be excluded from analysis to account for reactivity.
Main trial day:
In the 3 days prior to the main trial day, participants will be asked to record their food and drink intake and 48 hours before they should refrain from performing any strenuous physical activity. In the 24 hours prior participants should also refrain from consuming any alcohol or caffeine.
Participants should arrive at the Sports Training Village, University of Bath in the morning following a 10 hour fast where they will have their body composition precisely assessed using a dual-energy Xray absorptiometer (DEXA). They will then be taken to the Physiology Resting Laboratory where baseline expired gases will be collected for assessment of resting metabolic rate (RMR). A cannula will be inserted into a forearm vein and baseline blood sample(s) taken for analysis of metabolic/inflammatory markers and isolation of T cells. A fat sample will also be obtained using a needle aspiration technique.
The participant will then be asked to consume a breakfast type meal that is high in carbohydrate and fat contents consisting of brioche, jam, butter, and milkshake which has been adapted from a meal used by Rijkelijkhuizen J. et al, 2008, which induced stronger beta cell responses (i.e. of insulin) compared to a glucose load and showed differences with insulin sensitivity, so this meal type should identify differences in metabolism based on adiposity.
Furthermore, there is some evidence that high starch/low fibre foods may induce greater inflammation (Manning, Sutherland et al. 2008). The meal composition for all individuals will be identical but the energy content from carbohydrate will be calculated as a portion of the individuals' resting metabolic rate. This allows standardisation of energy intake for differences body weight/composition and will reflect energy requirements of the individual whilst at rest.
The meal should be consumed within 15 minutes and blood samples will be taken from the cannula at 15, 30, 60, and 90 minutes and then at every hour for 6 hours after consumption of the meal to monitor changes in metabolic and inflammatory markers. Additional blood samples will be obtained at 2 and 6 hours post meal by venepuncture for analysis of inflammatory markers as there is evidence that the cannula can stimulate local inflammation which interferes with the true result.
Expired gas samples for RMR will also be taken hourly and indirect calorimetry will be used to estimate relative fat and carbohydrate metabolism in response to the meal.
A second fat sample will be taken at 6 hours to examine inflammatory and metabolic responses to the meal within adipose tissue. A second blood sample for T cell isolation will also be obtained at this time point to examine corresponding metabolic/inflammatory responses in T cells.
Analysis:
On the day of the trial whole blood will be analysed for white blood cell count, glucose and lactate. Plasma and serum samples will be extracted from the whole blood via centrifugation and stored at -80. Monocytes and T lymphocytes (populations of white blood cells) will also be isolated from whole blood for later assessment of insulin sensitivity and culture experiments.
In each fat sample, separate portions of either adipose tissue or adipocytes (isolated from the other cells within the adipose tissue using a digestion method) will be cultured and media collected for later investigations. mRNA expression will also be examined in adipose tissue and isolated adipocytes. The remaining cells from the adipose tissue (SVF) will also be stored for later analysis of cell populations using flow cytometry, and expression/secretion analysis.
- Conditions
- Inflammation
- Being tested
- Consumption of a mixed meal
- Keywords
- Adipose tissue, metabolism, inflammation, post-prandial, human
- Medical subject headings
- Inflammation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Consumption of a mixed mealOther
Participants will consume a mixed meal and postprandial responses in blood and adipose tissue will be investigated over 6 hours and compared to baseline.
| Study group | Role | What they receive |
|---|---|---|
| Lean | Experimental | Consumption of a mixed meal relative to individual resting metabolic rate. Receives: Other: Consumption of a mixed meal |
| Overweight | Experimental | Consumption of a mixed meal relative to individual resting metabolic rate. Receives: Other: Consumption of a mixed meal |
| Obese | Experimental | Consumption of a mixed meal relative to individual resting metabolic rate. Receives: Other: Consumption of a mixed meal |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in IL6 mRNA expression in adipose tissue
mRNA expression of IL6 will be measured in adipose tissue samples obtained pre and 6 hours post consumption of the mixed meal to assess for postprandial inflammatory changes in adipose tissue.
Measured: 6 hours
Secondary outcomes (4)
Changes in IL-6 secretion by adipose tissue
Adipose tissue explants will be cultured for 3 hours using samples obtained before and 6 hours after the meal to assess for any changes in IL-6 secretion.
Measured: 6 hours
Analysis of insulin stimulated pathways
Activation/inhibition of insulin stimulated pathways in isolated adipocytes (by assessment of Akt/IRS1 phosphorylation by western blot analysis) will be assessed before and 6 hours after the meal.
Measured: 6 hours
Characterisation of immune cell populations in adipose tissue
Adipose tissue samples will be examined for their resident immune cell populations and compared to those in blood and characterised according to their respective activation statuses, in particular CD4+ and CD8+ T lymphocytes using flow cytometry analysis.
Measured: 6 hours
Effect of adipocytes on T Lymphocyte activation
To examine whether adipocytes influence T lymphocyte function/ability to activate (following stimulation) before and after a meal by culture/stimulation of isolated T cells with their own adipocyte culture media pre and post - meal (analysis of proliferation and activation by flow cytometry).
Measured: 6 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2015 (estimated)
- Study startSep 2011
- Primary completionNov 2014
- Study completionNov 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for InflammationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Bath
- Sponsor type
- University, hospital or other
- Collaborators
- Biotechnology and Biological Sciences Research Council, Unilever R&D
- Responsible party
- Principal investigator, Rebecca Travers, University of Bath
- Investigators
- Dylan Thompson, PhD, Principal investigator, University of BathJames A Betts, PhD, Principal investigator, Univeristy of BathAlexandre C Motta, PhD, Principal investigator, Unilever R&DRebecca L Travers, PhD, Principal investigator, University of Bath
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02416843
- Sponsor's protocol ID
- 11/SW/0193
- Status last verified
- Apr 2015
- First submitted
- 1 Apr 2015
- Last updated
- 16 Apr 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Metabolic and Immune System Responses to a Mixed Meal in Human Adipose Tissue and the Circulation
- ClinicalTrials.gov ID
- NCT02416843
- Acronym / sponsor ID
- 11/SW/0193
- Conditions
- Inflammation
- Keywords
- Adipose tissue, metabolism, inflammation, post-prandial, human
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- University of BathUniversity, hospital or other
- Collaborators
- Biotechnology and Biological Sciences Research Council, Unilever R&D
- Study start
- Sep 2011
- Primary completion
- Nov 2014 (actual)
- Study completion
- Nov 2014 (actual)
- First posted
- 15 Apr 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Overweight and obesity are major problems and their complications such as cardiovascular disease and type 2 diabetes mellitus pose great burdens on healthcare systems. There is accumulating evidence to support obesity being a chronic inflammatory disorder mediated in part by the expansion of adipose (fat) tissue.
Knowledge of the role of adipose tissue itself has changed dramatically and it has emerged that in addition to storing energy as fats; adipose tissue secretes and responds to various chemical messengers in the body that are related to metabolism and inflammation. After a meal has been consumed, changes in metabolic (and some inflammatory) markers are seen in the blood, which may be influenced by metabolic and inflammatory changes occuring in the adipose tissue itself.
The investigators therefore plan to investigate these changes in adipose tissue before and after a meal and compare them to changes occurring in the blood. They also plan to investigate whether these responses are different in people who are overweight compared to 'normal' weight.
Participants will include males aged between 35-55 years who fit the criteria for inclusion. After taking some preliminary measurements and monitoring of normal daily activities, participants will attend one day of Laboratory testing in the Physiology Laboratories at the University of Bath.
By investigating differences in metabolism and inflammation in adipose tissue and the circulation it is hoped that more will be learnt about the development of diseases associated with being overweight and ultimately help to develop more effective methods for prevention and treatment.
Detailed description
The aim of this research is to investigate differences in metabolism and inflammation in adipose tissue and the circulation in response to a meal with increasing adiposity. It is hypothesised that participants with increased fat mass, will have a more pronounced inflammatory response to a meal compared to participants with a 'healthy' weight. The inflammatory response will be assessed by measuring changes in gene expression and protein secretion in the adipose tissue and by measuring markers of metabolism, insulin resistance, cardiovascular disease and inflammation in the blood.
Following advertisement of the study, interested potential participants will be asked to contact the Chief Investigator for further information via email/telephone correspondence. There will be an initial assessment of eligibility based on inclusion/exclusion criteria and, if these requirements are met, the potential participant will be invited to a meeting to further discuss the trial. After they have read the participant information sheet and seen the flowchart outlining the timeline for the study, if they would like to take part, they will be asked to sign a consent form. Dates will then be scheduled for some preliminary anthropometric measurements to be taken, 9 days of physical activity monitoring and the trial date (1 full day in the laboratory only).
Preliminary measurements:
Preliminary testing will include anthropometric measurements of height, weight, waist and hip circumferences, sagittal waist height and blood pressure. These measurements will take place at the University of Bath Physiology Laboratories.
Physical activity monitoring:
For 9 days, participants will be fitted with a physical activity monitor (Actiheart™) and asked to record a corresponding diary of their physical activity during this period to aid its interpretation and allow a more accurate calculation of average daily activity energy expenditure. Participants should not make any conscious changes to their normal lifestyle habits/routines during this period. The first 2 days of activity monitoring will be excluded from analysis to account for reactivity.
Main trial day:
In the 3 days prior to the main trial day, participants will be asked to record their food and drink intake and 48 hours before they should refrain from performing any strenuous physical activity. In the 24 hours prior participants should also refrain from consuming any alcohol or caffeine.
Participants should arrive at the Sports Training Village, University of Bath in the morning following a 10 hour fast where they will have their body composition precisely assessed using a dual-energy Xray absorptiometer (DEXA). They will then be taken to the Physiology Resting Laboratory where baseline expired gases will be collected for assessment of resting metabolic rate (RMR). A cannula will be inserted into a forearm vein and baseline blood sample(s) taken for analysis of metabolic/inflammatory markers and isolation of T cells. A fat sample will also be obtained using a needle aspiration technique.
The participant will then be asked to consume a breakfast type meal that is high in carbohydrate and fat contents consisting of brioche, jam, butter, and milkshake which has been adapted from a meal used by Rijkelijkhuizen J. et al, 2008, which induced stronger beta cell responses (i.e. of insulin) compared to a glucose load and showed differences with insulin sensitivity, so this meal type should identify differences in metabolism based on adiposity.
Furthermore, there is some evidence that high starch/low fibre foods may induce greater inflammation (Manning, Sutherland et al. 2008). The meal composition for all individuals will be identical but the energy content from carbohydrate will be calculated as a portion of the individuals' resting metabolic rate. This allows standardisation of energy intake for differences body weight/composition and will reflect energy requirements of the individual whilst at rest.
The meal should be consumed within 15 minutes and blood samples will be taken from the cannula at 15, 30, 60, and 90 minutes and then at every hour for 6 hours after consumption of the meal to monitor changes in metabolic and inflammatory markers. Additional blood samples will be obtained at 2 and 6 hours post meal by venepuncture for analysis of inflammatory markers as there is evidence that the cannula can stimulate local inflammation which interferes with the true result.
Expired gas samples for RMR will also be taken hourly and indirect calorimetry will be used to estimate relative fat and carbohydrate metabolism in response to the meal.
A second fat sample will be taken at 6 hours to examine inflammatory and metabolic responses to the meal within adipose tissue. A second blood sample for T cell isolation will also be obtained at this time point to examine corresponding metabolic/inflammatory responses in T cells.
Analysis:
On the day of the trial whole blood will be analysed for white blood cell count, glucose and lactate. Plasma and serum samples will be extracted from the whole blood via centrifugation and stored at -80. Monocytes and T lymphocytes (populations of white blood cells) will also be isolated from whole blood for later assessment of insulin sensitivity and culture experiments.
In each fat sample, separate portions of either adipose tissue or adipocytes (isolated from the other cells within the adipose tissue using a digestion method) will be cultured and media collected for later investigations. mRNA expression will also be examined in adipose tissue and isolated adipocytes. The remaining cells from the adipose tissue (SVF) will also be stored for later analysis of cell populations using flow cytometry, and expression/secretion analysis.
Study design
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Lean | Experimental | Other: Consumption of a mixed mealConsumption of a mixed meal relative to individual resting metabolic rate. |
| Overweight | Experimental | Other: Consumption of a mixed mealConsumption of a mixed meal relative to individual resting metabolic rate. |
| Obese | Experimental | Other: Consumption of a mixed mealConsumption of a mixed meal relative to individual resting metabolic rate. |
Who may qualify
- Ages
- 35 to 55 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Nonsmokers
- Weight stable for more than 3 months
Key exclusion criteria (5 listed)
- have a personal history of/existing cardiovascular disease, metabolic disease or dyslipidaemia
- be taking medications that may influence lipid or carbohydrate metabolism
- have food intolerances/allergies to any component of the meal (i.e. dairy or wheat)
- Perform no more than 6 hours of strenuous physical activity or 10 hours of moderate intensity physical activity per week (as these individuals will not fit the meal standardisation procedure)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Consumption of a mixed mealParticipants will consume a mixed meal and postprandial responses in blood and adipose tissue will be investigated over 6 hours and compared to baseline. | Other | Lean, Obese, Overweight |
Primary outcome
Changes in IL6 mRNA expression in adipose tissue
Time frame: 6 hours
mRNA expression of IL6 will be measured in adipose tissue samples obtained pre and 6 hours post consumption of the mixed meal to assess for postprandial inflammatory changes in adipose tissue.
4 secondary outcomes
Changes in IL-6 secretion by adipose tissue
Time frame: 6 hours
Analysis of insulin stimulated pathways
Time frame: 6 hours
Characterisation of immune cell populations in adipose tissue
Time frame: 6 hours
Effect of adipocytes on T Lymphocyte activation
Time frame: 6 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2015.
Related trials for Inflammation
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 4
Lidocaine Infiltration and Neuroimmunomodulation in Head and Neck Cancer Surgery
Head and Neck Cancer (H&N)
Active, not recruiting
CT for Personalized Mechanical Ventilation
Ventilator-Induced Lung Injury, Sepsis Syndrome
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dylan Thompson, PhD principal investigator
University of Bath
James A Betts, PhD principal investigator
Univeristy of Bath
Alexandre C Motta, PhD principal investigator
Unilever R&D
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Consumption of a mixed meal in people with Inflammation, run by University of Bath at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in IL6 mRNA expression in adipose tissue (time frame: 6 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2015.